Display options
Cite
Tamam C, Tamam M, Mulazimoglu M. The Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Bone Lesions of Undetermined Origin. World J Nucl Med. 2016;15(2):124-9doi: 10.4103/1450-1147.176885.
Tamam, C., Tamam, M., & Mulazimoglu, M. (2016). The Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Bone Lesions of Undetermined Origin. World journal of nuclear medicine, 15(2), 124-9. https://doi.org/10.4103/1450-1147.176885
Tamam, Cuneyt, et al. "The Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Bone Lesions of Undetermined Origin." World journal of nuclear medicine vol. 15,2 (2016): 124-9. doi: https://doi.org/10.4103/1450-1147.176885
Tamam C, Tamam M, Mulazimoglu M. The Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Bone Lesions of Undetermined Origin. World J Nucl Med. 2016 May-Aug;15(2):124-9. doi: 10.4103/1450-1147.176885. PMID: 27134563; PMCID: PMC4809153.
Copy Download .nbib Format: NLM
Share it on

World J Nucl Med. 2016 May-Aug;15(2):124-9. doi: 10.4103/1450-1147.176885.

The Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Bone Lesions of Undetermined Origin.

World journal of nuclear medicine

Cuneyt Tamam, Muge Tamam, Mehmet Mulazimoglu

Affiliations

  1. Department of Orthopedics and Traumatology, Kasimpasa Military Hospital, Istanbul, Turkey.
  2. Department of Nuclear Medicine, Okmeydani Training and Research Hospital, Istanbul, Turkey.

PMID: 27134563 PMCID: PMC4809153 DOI: 10.4103/1450-1147.176885

Abstract

The aim of the current study was to determine the diagnostic accuracy of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting carcinoma of unknown primary (CUP) with bone metastases. We evaluated 87 patients who were referred to FDG-PET/CT imaging and reported to have skeletal lesions with suspicion of malignancy. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated. The median survival rate was measured to evaluate the prognostic value of the FDG-PET/CT findings. In the search for a primary, FDG-PET/CT findings correctly diagnosed lesions as the site of the primary true positive (TP) in 64 (73%) cases, 4 (5%) findings diagnosed no site of a primary, and none were subsequently proven to be true negative (TN); 14 (16%) diagnoses were false positive (FP) and 5 (6%) diagnoses were false negative (FN). Life expectancy was between 2 months and 25 months. Whole-body FDG-PET/CT imaging may be a useful method in assessing the bone lesions with suspicion of bone metastases.

Keywords: 18-fluorodeoxyglucose positron emission tomography/computed tomography; Bone lesions; carcinoma of unknown primary; granulomatous disease

References

  1. J Bone Joint Surg Am. 1993 Sep;75(9):1276-81 - PubMed
  2. Nucl Med Commun. 2003 Oct;24(10 ):1081-6 - PubMed
  3. Crit Rev Oncol Hematol. 2009 Mar;69(3):271-8 - PubMed
  4. J Clin Oncol. 1995 Aug;13(8):2094-103 - PubMed
  5. Semin Oncol. 1993 Jun;20(3):238-43 - PubMed
  6. JAMA. 2003 Dec 24;290(24):3199-206 - PubMed
  7. Nucl Med Commun. 2008 Sep;29(9):791-802 - PubMed
  8. Eur Radiol. 2003 Sep;13(9):2119-21 - PubMed
  9. Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):683-6 - PubMed
  10. Med Hypotheses. 2002 Sep;59(3):357-60 - PubMed
  11. Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1783-92 - PubMed
  12. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1305-15 - PubMed
  13. Anticancer Res. 2005 Mar-Apr;25(2B):1421-6 - PubMed
  14. Cancer. 1998 Mar 15;82(6):1160-6 - PubMed
  15. Ann Hematol. 2009 Dec;88(12 ):1161-8 - PubMed
  16. Nucl Med Commun. 2010 Jan;31(1):59-66 - PubMed
  17. J Nucl Med. 2008 Feb;49(2):195-200 - PubMed
  18. J Cancer Res Clin Oncol. 2010 Aug;136(8):1125-34 - PubMed
  19. Cancer. 2007 Jan 15;109 (2):292-9 - PubMed
  20. Q J Nucl Med Mol Imaging. 2006 Mar;50(1):15-22 - PubMed
  21. J Nucl Med. 2003 Aug;44(8):1301-14 - PubMed
  22. Eur Radiol. 2009 Mar;19(3):731-44 - PubMed
  23. Tumori. 2010 Jan-Feb;96(1):111-6 - PubMed
  24. AJR Am J Roentgenol. 2005 Apr;184(4):1199-204 - PubMed
  25. Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):635-44 - PubMed
  26. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1794-802 - PubMed

Publication Types